Eleonora Cerchiaro

Saronno, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Avelumab Treatment in Very Elderly People With Advanced Merkel Cell Carcinoma: A Case Report and Review of the Literature.

Avelumab Treatment in Very Elderly People With Advanced Merkel Cell Carcinoma: A Case Report and Review of the Literature.

Journal: Cureus
Published: November 24, 2025

Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer.

Survival outcome of tyrosine kinase inhibitors beyond progression in association to radiotherapy in oligoprogressive EGFR-mutant non-small-cell lung cancer.

Journal: Future oncology (London, England)
Published: November 12, 2019

Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.

Impact of Exon 19 Deletion Subtypes in EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer Treated With First-Line Tyrosine Kinase Inhibitors.

Journal: Clinical lung cancer
Published: April 30, 2018

Clinical staging of malignant pleural mesothelioma: current perspectives.

Clinical staging of malignant pleural mesothelioma: current perspectives.

Journal: Lung Cancer (Auckland, N.Z.)
Published: September 02, 2017

DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.

DEBIRI plus capecitabine: a treatment option for refractory liver-dominant metastases from colorectal cancer.

Journal: Future oncology (London, England)
Published: April 26, 2017

Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.

Conversion Chemotherapy for Technically Unresectable Colorectal Liver Metastases: A Retrospective, STROBE-Compliant, Single-Center Study Comparing Chemotherapy Alone and Combination Chemotherapy With Cetuximab or Bevacizumab.

Journal: Medicine
Published: May 20, 2016

Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.

Different EGFR Gene Mutations in Exon 18, 19 and 21 as Prognostic and Predictive Markers in NSCLC: A Single Institution Analysis.

Journal: Molecular diagnosis & therapy
Published: December 10, 2015

KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.

KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study.

Journal: Molecular diagnosis & therapy
Published: November 28, 2015

Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.

Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.

Journal: Clinical breast cancer
Published: February 03, 2015

Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.

Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.

Journal: Cardiovascular and interventional radiology
Published: July 19, 2014
Showing 1-10 of 10

Last Updated: 09/26/2026